These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24561328)

  • 21. Drugs and dilated cardiomyopathies: A case/noncase study in the French PharmacoVigilance Database.
    Montastruc G; Favreliere S; Sommet A; Pathak A; Lapeyre-Mestre M; Perault-Pochat MC; Montastruc JL;
    Br J Clin Pharmacol; 2010 Mar; 69(3):287-94. PubMed ID: 20233200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterisation of Agomelatine-Induced Increase in Liver Enzymes: Frequency and Risk Factors Determined from a Pooled Analysis of 7605 Treated Patients.
    Perlemuter G; Cacoub P; Valla D; Guyader D; Saba B; Batailler C; Moore K
    CNS Drugs; 2016 Sep; 30(9):877-88. PubMed ID: 27342740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The drugs that mostly frequently induce gynecomastia: A national case - noncase study.
    Batteux B; Llopis B; Muller C; Khouri C; Moragny J; Liabeuf S; Masmoudi K; Gras V;
    Therapie; 2020; 75(3):225-238. PubMed ID: 31471065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Agomelatine: to be avoided, with or without a "patient booklet".
    Prescrire Int; 2015 Dec; 24(166):294. PubMed ID: 26788574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Notoriety bias in a database of spontaneous reports: the example of osteonecrosis of the jaw under bisphosphonate therapy in the French national pharmacovigilance database.
    de Boissieu P; Kanagaratnam L; Abou Taam M; Roux MP; Dramé M; Trenque T
    Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):989-92. PubMed ID: 24737486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Agomelatine-induced hepatotoxicity.
    Štuhec M
    Wien Klin Wochenschr; 2013 Apr; 125(7-8):225-6. PubMed ID: 23519541
    [No Abstract]   [Full Text] [Related]  

  • 27. Memory disorders associated with consumption of drugs: updating through a case/noncase study in the French PharmacoVigilance Database.
    Chavant F; Favrelière S; Lafay-Chebassier C; Plazanet C; Pérault-Pochat MC
    Br J Clin Pharmacol; 2011 Dec; 72(6):898-904. PubMed ID: 21557759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety profile of antiviral medications: a pharmacovigilance study using the Italian spontaneous-reporting database.
    Pugi A; Bonaiuti R; Maggini V; Moschini M; Tuccori M; Leone R; Rossi M; Motola D; Piccinni C; Ferrazin F; Sottosanti L; Mugelli A; Vannacci A; Lapi F
    Am J Health Syst Pharm; 2013 Jun; 70(12):1039-46. PubMed ID: 23719881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Agomelatine: an antidepressant with new potent hepatoprotective effects on paracetamol-induced liver damage in rats.
    Karakus E; Halici Z; Albayrak A; Polat B; Bayir Y; Kiki I; Cadirci E; Topcu A; Aksak S
    Hum Exp Toxicol; 2013 Aug; 32(8):846-57. PubMed ID: 23584358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suspected adverse drug reaction reports with oral anticoagulants in Portugal: a pharmacovigilance study.
    Caldeira D; Rodrigues R; Abreu D; Anes AM; Rosa MM; Ferreira JJ
    Expert Opin Drug Saf; 2018 Apr; 17(4):339-345. PubMed ID: 29463153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver injury with novel oral anticoagulants: assessing post-marketing reports in the US Food and Drug Administration adverse event reporting system.
    Raschi E; Poluzzi E; Koci A; Salvo F; Pariente A; Biselli M; Moretti U; Moore N; De Ponti F
    Br J Clin Pharmacol; 2015 Aug; 80(2):285-93. PubMed ID: 25689417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statins and erectile dysfunction: results of a case/non-case study using the French Pharmacovigilance System Database.
    Do C; Huyghe E; Lapeyre-Mestre M; Montastruc JL; Bagheri H
    Drug Saf; 2009; 32(7):591-7. PubMed ID: 19530745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database.
    Gastaldon C; Schoretsanitis G; Arzenton E; Raschi E; Papola D; Ostuzzi G; Moretti U; Seifritz E; Kane JM; Trifirò G; Barbui C
    Drug Saf; 2022 Dec; 45(12):1539-1549. PubMed ID: 36400895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Was the thrombotic risk of rofecoxib predictable from the French Pharmacovigilance Database before 30 September 2004?
    Sommet A; Grolleau S; Bagheri H; Lapeyre-Mestre M; Montastruc JL;
    Eur J Clin Pharmacol; 2008 Aug; 64(8):829-34. PubMed ID: 18509626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project.
    Raschi E; Poluzzi E; Salvo F; Koci A; Suling M; Antoniazzi S; Perina L; Hazell L; Moretti U; Sturkenboom M; Garbe E; Pariente A; De Ponti F
    Drug Saf; 2016 Jan; 39(1):59-68. PubMed ID: 26446144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surveillance of drugs that most frequently induce acute kidney injury: A pharmacovigilance approach.
    Hosohata K; Inada A; Oyama S; Furushima D; Yamada H; Iwanaga K
    J Clin Pharm Ther; 2019 Feb; 44(1):49-53. PubMed ID: 30014591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: unified list based on international collaborative work.
    Suzuki A; Andrade RJ; Bjornsson E; Lucena MI; Lee WM; Yuen NA; Hunt CM; Freston JW
    Drug Saf; 2010 Jun; 33(6):503-22. PubMed ID: 20486732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antidepressant-Induced Acute Liver Injury: A Case-Control Study in an Italian Inpatient Population.
    Ferrajolo C; Scavone C; Donati M; Bortolami O; Stoppa G; Motola D; Vannacci A; Mugelli A; Leone R; Capuano A;
    Drug Saf; 2018 Jan; 41(1):95-102. PubMed ID: 28770534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative effects of 15 antidepressants on the risk of withdrawal syndrome: A real-world study using the WHO pharmacovigilance database.
    Quilichini JB; Revet A; Garcia P; Bouquié R; Hamard J; Yrondi A; Montastruc F
    J Affect Disord; 2022 Jan; 297():189-193. PubMed ID: 34699855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-induced hepatic injury in children: a case/non-case study of suspected adverse drug reactions in VigiBase.
    Ferrajolo C; Capuano A; Verhamme KM; Schuemie M; Rossi F; Stricker BH; Sturkenboom MC
    Br J Clin Pharmacol; 2010 Nov; 70(5):721-8. PubMed ID: 21039766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.